Clarke C H, Nicholson A N
Br J Clin Pharmacol. 1978 Oct;6(4):325-31. doi: 10.1111/j.1365-2125.1978.tb00859.x.
Immediate and residual effects of diazepam and its metabolites on visuomotor co-ordination have been studied in man. Performance was observed from 10.0-16.0 h after overnight ingestion of diazepam (5 and 10 mg), temazepam (10, 20 and 30 mg), oxazepam (15, 30 and 45 mg) and nordiazepam (5 and 10 mg), and from 0.5-6.5 h after morning ingestion of diazepam (10 mg), temazepam (20 mg), oxazepam (30 mg), and nordiazepam (5 and 10 mg). Immediate and residual effects of diazepam and temazepam were also studied on a choice response time test. Visuo-motor co-ordination was not impaired after the overnight ingestion of 5 and 10 mg diazepam, 10, 20 and 30 mg temazepam, 15 and 30 mg oxazepam and 5 and 10 mg nordiazepam, though there was a trend of impaired performance over the dose range used with temazepam 10.0 h after ingestion. With 45 mg oxazepam performance at 10.0 h was impaired compared with performance at 14.0 ( < 0.01) and 16.0 h ( < 0.001). Performance on the choice response time test was not impaired after the overnight ingestion of 5 and 10 mg diazepam and 10, 20 and 30 mg temazepam. With morning ingestion visuo-motor co-ordination was impaired at 0.5 ( < 0.01) and 2.5 h ( < 0.05) after 10 mg diazepam, at 0.5 ( < 0.001) after 20 mg temazepam, and at 2.5 ( < 0.01) and 4.5 h ( < 0.05) after 30 mg oxazepam. Performance 6.5 h after 10 mg nordiazepam was impaired compared with performance 0.5 and 2.5 h ( < 0.01) after ingestion. Performance on the choice response time test was impaired 1.0 h after ingestion of 10 mg diazepam ( < 0.01) and 20 mg temazepam ( < 0.05). It is considered that diazepam (5-10 mg), temazepam (10-20 mg) and oxazepam (15-30 mg) would be useful hypnotics within the dose ranges indicated, at least for occasional use, when impaired performance the next day would be unacceptable. The studies with nordiazepam suggest that, though this drug may have limited effects on performance, it may have persistent effects on behaviour consistent with its clinical use as an anxiolytic.
地西泮及其代谢产物对人体视觉运动协调能力的即时和残留影响已得到研究。在过夜服用地西泮(5毫克和10毫克)、替马西泮(10毫克、20毫克和30毫克)、奥沙西泮(15毫克、30毫克和45毫克)和去甲地西泮(5毫克和10毫克)后的10.0至16.0小时,以及早晨服用地西泮(10毫克)、替马西泮(20毫克)、奥沙西泮(30毫克)和去甲地西泮(5毫克和10毫克)后的0.5至6.5小时观察了相关表现。还在地西泮和替马西泮的选择反应时间测试中研究了即时和残留影响。过夜服用5毫克和10毫克地西泮、10毫克、20毫克和30毫克替马西泮、15毫克和30毫克奥沙西泮以及5毫克和10毫克去甲地西泮后,视觉运动协调能力未受损,尽管在摄入替马西泮10.0小时后,在所使用的剂量范围内存在表现受损的趋势。服用45毫克奥沙西泮后,10.0小时的表现与14.0小时(<0.01)和16.0小时(<0.001)的表现相比受损。过夜服用5毫克和10毫克地西泮以及10毫克、20毫克和30毫克替马西泮后,选择反应时间测试的表现未受损。早晨摄入后,10毫克地西泮在0.5小时(<0.01)和2.5小时(<0.05)时视觉运动协调能力受损,20毫克替马西泮在0.5小时(<0.001)时受损,30毫克奥沙西泮在2.5小时(<0.01)和4.5小时(<0.05)时受损。与摄入后0.5小时和2.5小时的表现相比,10毫克去甲地西泮在6.5小时时表现受损(<0.01)。摄入10毫克地西泮(<0.01)和20毫克替马西泮(<0.05)后1.0小时,选择反应时间测试的表现受损。据认为,地西泮(5 - 10毫克)、替马西泮(10 - 20毫克)和奥沙西泮(15 - 30毫克)在所示剂量范围内将是有用的催眠药,至少偶尔使用时,第二天表现受损是不可接受的情况。去甲地西泮的研究表明,尽管这种药物对表现的影响可能有限,但它可能对行为有持续影响,这与其作为抗焦虑药的临床用途一致。